Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
532.00    -1.00 (-0.19%)
Bid:
529.00
Ask:
532.00
Spread: 3.00 (0.567%)
Market Cap: £306.51m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Directorate changes

11 Dec 2025 07:00

RNS Number : 0703L
Mortgage Advice Bureau (Hldgs) PLC
11 December 2025
 

11 December 2025

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

 

Directorate Changes

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-driven UK mortgage network and broker, announces the following changes to the Board:

 

Appointment of Chief Operating Officer (COO) to the Board

MAB has appointed Yaiza Patricia Luengo Morales (Yaiza Luengo), COO, to the Board with effect from 1 January 2026, subject to regulatory approvals.

 

Yaiza joined MAB as COO and member of the Executive Committee on 8 September 2025. She brings over 20 years' international experience in financial services, with a strong track record in large-scale transformation, revenue leadership and operational restructuring in regulated environments. She has led technology-enabled change across cloud and data architecture, Artificial Intelligence (AI), digital customer experience and enterprise platforms. Her previous senior executive roles include positions at RBS, Barclays, HSBC, Refinitiv (now part of LSEG), and WiZink Bank.

 

Deputy Chief Executive Officer (Deputy CEO) to step down from the Board

Ben Thompson will step down as Deputy CEO and as a director of MAB with effect from 31 December 2025. As previously announced, Ben will transition into a newly created strategic role focused on building new value by optimising MAB's mortgage opportunity and broadening and strengthening its customer proposition.

 

Mike Jones, Non-Executive Chair, said:

"Yaiza has already made a positive impact since joining MAB as Chief Operating Officer. Her considerable operational experience and technology background will provide important leadership as we deliver on our medium-term growth targets, and we are pleased to welcome her to the Board.

 

Since joining the Group in 2018, Ben has been a key member of the team that has delivered significant revenue and market share growth at MAB. I am delighted that his major contribution to the business will continue in his new strategic role."

 

Regulatory disclosures

The following information is provided in accordance with AIM Rule 17 and Schedule Two (g) of the AIM Rules for Companies:

Yaiza Luengo, aged 44 years, currently holds or has held the following directorships and partnerships in the last five years:

Current Directorships/Partnerships

Casalogica Ltd - Director

 

People Risk Management Limited - Director

 

Big Wave Studios AI Ltd - Director

 

Clinsj AS (a Norwegian company) - Director

 

Yaiza Luengo holds options over 77,509 shares in MAB, subject to the relevant plan rules.

 

MAB is not aware of any further disclosures required under these provisions with respect to the appointment of Yaiza Luengo.

 

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

 

Peter Brodnicki, Chief Executive Officer

Emilie McCarthy, Chief Financial Officer 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Jason Grossman / Francis North

 

 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons 

 

 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Thomas Philpot / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk

 

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

Through its partner firms known as Appointed Representatives (ARs), MAB has over 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKAEFEKSFFA
Date   Source Headline
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSBusiness Update
31st Jan 20253:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
15th Jan 202512:06 pmRNSDirector/PDMR Shareholding
14th Jan 20253:09 pmRNSBlock listing Interim Review
13th Jan 20259:19 amRNSHolding(s) in Company
31st Dec 202411:56 amRNSDirector/PDMR Shareholding
17th Dec 202411:40 amRNSDirectors' Shareholdings and PDMR notification
2nd Dec 202411:40 amRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSDirector/PDMR Shareholding
14th Nov 202411:09 amRNSDirector/PDMR Shareholding
13th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNotice of Capital Markets Day
12th Nov 20249:14 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSAppointment of Nominated Adviser and Joint Broker
4th Nov 20249:09 amRNSDirectors' Shareholdings and PDMR notification
28th Oct 20249:43 amRNSNotification of Major Holdings
15th Oct 20242:47 pmRNSDirectors' Shareholdings and PDMR notification
4th Oct 202412:16 pmRNSDirectors' Shareholdings and PDMR Notification
2nd Oct 20245:15 pmRNSNotification of Major Holdings
30th Sep 20244:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Sep 202411:58 amRNSDirectors' Shareholdings and PDMR notification
30th Sep 20249:42 amRNSDirectors' Shareholdings and PDMR notification
25th Sep 20247:00 amRNSDirectors' Shareholdings and PDMR notification
24th Sep 20247:00 amRNSInterim Results
17th Sep 20241:44 pmRNSDirectors' Shareholdings and PDMR notification
17th Sep 20249:16 amRNSNotification of Major Holdings
30th Aug 20245:17 pmRNSDirectors' Shareholdings and PDMR notification
15th Aug 20243:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Jul 20245:35 pmRNSDirectors' Shareholdings and PDMR notification
25th Jul 20247:00 amRNSTrading Update
22nd Jul 20248:02 amRNSDirectors' Shareholdings and PDMR notification
22nd Jul 20247:00 amRNSDirectors' Shareholdings and PDMR notification
12th Jul 20241:19 pmRNSBlock listing Interim Review
1st Jul 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20241:57 pmRNSNotification of Major Holdings
25th Jun 20247:00 amRNSNotification of Major Holdings
21st Jun 20243:06 pmRNSNotification of Major Holdings
17th Jun 20245:49 pmRNSDirector/PDMR Shareholding
13th Jun 202412:39 pmRNSDirector/PDMR Shareholding and TVR
12th Jun 20244:46 pmRNSNotification of Major Holdings
4th Jun 20244:18 pmRNSNotification of Major Holdings
31st May 202410:36 amRNSDirectors' Shareholdings and PDMR notification
29th May 20247:00 amRNSRelated Party Transaction
28th May 20243:56 pmRNSNotification of Major Holdings
23rd May 20247:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.